All Stories

  1. Efficacy of low-protein rice for dietary protein restriction in CKD patients: A multicenter randomized controlled study
  2. Physiological Mechanisms of Hypertension and Cardiovascular Disease in End-Stage Kidney Disease
  3. Comparative Effectiveness of Dialysis Modality on Laboratory Parameters of Mineral Metabolism
  4. Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial
  5. Correcting anemia and native vitamin D supplementation in kidney transplant recipients: a multicenter, 2 × 2 factorial, open‐label, randomized clinical trial
  6. The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study
  7. Laxative Use and Risk of Dyskalemia in Patients with Advanced CKD Transitioning to Dialysis
  8. Residual Urine Output and Mortality in a Prospective Hemodialysis Cohort
  9. Ultrafiltration Rate, Residual Kidney Function, and Survival Among Patients Treated With Reduced-Frequency Hemodialysis
  10. Primary causes of kidney disease and mortality in dialysis-dependent children
  11. Comparing Patient Survival of Home Hemodialysis and Peritoneal Dialysis Patients
  12. Hemodynamic and Laboratory Changes during Incremental Transition from Twice to Thrice-Weekly Hemodialysis
  13. 2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report
  14. Association of Mineral Bone Disorder With Decline in Residual Kidney Function in Incident Hemodialysis Patients
  15. Machine Learning to Identify Dialysis Patients at High Death Risk
  16. Serum triglycerides and mortality risk across stages of chronic kidney disease in 2 million U.S. veterans
  17. Association of Pre-End-Stage Renal Disease Serum Albumin With Post-End-Stage Renal Disease Outcomes Among Patients Transitioning to Dialysis
  18. Seasonal variation of serum 25-hydroxyvitamin D and parameters of bone and mineral disorder in dialysis patients
  19. Serum albumin and hospitalization among pediatric patients with end-stage renal disease who started dialysis therapy
  20. Estimated GFR at Dialysis Initiation and Mortality in Children and Adolescents
  21. Factors Associated With Withdrawal From Dialysis Therapy in Incident Hemodialysis Patients Aged 80 Years or Older
  22. A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD
  23. Statin Therapy Before Transition to End‐Stage Renal Disease With Posttransition Outcomes
  24. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States
  25. Visit-to-visit variability in estimated glomerular filtration rate predicts hospitalization and death due to cardiovascular events
  26. Mean Corpuscular Volume and Mortality in Incident Hemodialysis Patients
  27. Racial and Ethnic Differences in Mortality Associated with Serum Potassium in Incident Peritoneal Dialysis Patients
  28. Ultrafiltration Rate Effects Declines in Residual Kidney Function in Hemodialysis Patients
  29. Individualized Hemodialysis Treatment: A Perspective on Residual Kidney Function and Precision Medicine in Nephrology
  30. Development and Validation of Prediction Scores for Early Mortality at Transition to Dialysis
  31. Vascular access placement and mortality in elderly incident hemodialysis patients
  32. Predialysis Kidney Function and Its Rate of Decline Predict Mortality and Hospitalizations After Starting Dialysis
  33. Red blood cell distribution width and mortality and hospitalizations in peritoneal dialysis patients
  34. Precision Medicine in the Transition to Dialysis and Personalized Renal Replacement Therapy
  35. Dialysis Provider and Outcomes among United States Veterans Who Transition to Dialysis
  36. Proteinuria-associated renal magnesium wasting leads to hypomagnesemia: a common electrolyte abnormality in chronic kidney disease
  37. Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis?
  38. High and low estimated glomerular filtration rates are associated with adverse outcomes in patients undergoing surgery for gastrointestinal malignancies
  39. Impact of residual kidney function on hemodialysis adequacy and patient survival
  40. Association of Pre-ESRD Serum Calcium With Post-ESRD Mortality Among Incident ESRD Patients: A Cohort Study
  41. In response to ‘benefits and risks of intensive blood-pressure lowering in advanced chronic kidney disease’
  42. Parathyroidectomy in the Management of Secondary Hyperparathyroidism
  43. US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States
  44. Weekly Standard Kt/Vurea and Clinical Outcomes in Home and In-Center Hemodialysis
  45. Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes
  46. No Survival Benefit in Octogenarians and Nonagenarians with Extended Hemodialysis Treatment Time
  47. Impact of Obesity on Modality Longevity, Residual Kidney Function, Peritonitis, and Survival Among Incident Peritoneal Dialysis Patients
  48. A Randomized, Double-Blind, Crossover Pilot Trial of Rice Endosperm Protein Supplementation in Maintenance Hemodialysis Patients
  49. Anion Gap as a Determinant of Ionized Fraction of Divalent Cations in Hemodialysis Patients
  50. Estimated glomerular filtration rate and the risk-benefit profile of intensive blood pressure control amongst nondiabetic patients: a post hoc analysis of a randomized clinical trial
  51. Incremental and Once- to Twice-Weekly Hemodialysis: From Experience to Evidence
  52. Risk of Postoperative Venous Thromboembolism Among Pregnant Women
  53. Association of pre-operative estimated GFR on post-operative pulmonary complications in laparoscopic surgeries
  54. Longitudinal Associations among Renal Urea Clearance–Corrected Normalized Protein Catabolic Rate, Serum Albumin, and Mortality in Patients on Hemodialysis
  55. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function
  56. Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patients
  57. Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney Disease
  58. Introduction to the Critical Balance - Residual Kidney Function and Incremental Transition to Dialysis
  59. Prediction equation for calculating residual kidney urea clearance using urine collections for different hemodialysis treatment frequencies and interdialytic intervals
  60. Incremental Hemodialysis: The University of California Irvine Experience
  61. Modeling longitudinal data and its impact on survival in observational nephrology studies: tools and considerations
  62. US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States
  63. Seasonal variations in transition, mortality and kidney transplantation among patients with end-stage renal disease in the USA
  64. Transition of care from pre-dialysis prelude to renal replacement therapy: the blueprints of emerging research in advanced chronic kidney disease
  65. Incremental and infrequent hemodialysis: a new paradigm for both dialysis initiation and conservative management
  66. Vitamin D Receptor Activator Use and Cause-specific Death among dialysis Patients: a Nationwide Cohort Study using Coarsened Exact Matching
  67. Serum uric acid, protein intake and mortality in hemodialysis patients
  68. Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis
  69. Dietary protein intake and chronic kidney disease
  70. Racial and Ethnic Differences in Mortality Associated with Serum Potassium in a Large Hemodialysis Cohort
  71. Serum Ferritin Variations and Mortality in Incident Hemodialysis Patients
  72. Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis Patients
  73. Changes in urine volume and serum albumin in incident hemodialysis patients
  74. Intravenous Vitamin B6 Increases Resistance to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: A Randomized Controlled Trial
  75. Treatment frequency and mortality among incident hemodialysis patients in the United States comparing incremental with standard and more frequent dialysis
  76. Development and Validation of a Novel Laboratory-Specific Correction Equation for Total Serum Calcium and Its Association With Mortality Among Hemodialysis Patients
  77. Serum Magnesium Levels and Hospitalization and Mortality in Incident Peritoneal Dialysis Patients: A Cohort Study
  78. Association between Density of Coronary Artery Calcification and Serum Magnesium Levels among Patients with Chronic Kidney Disease
  79. Preservation of residual kidney function in hemodialysis patients: reviving an old concept
  80. Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study
  81. Hidden Hypercalcemia and Mortality Risk in Incident Hemodialysis Patients
  82. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy
  83. Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients
  84. Association of serum vitamin B12 and folate with mortality in incident hemodialysis patients
  85. Yet Another Vitamin D Analogue for the Management of Secondary Hyperparathyroidism: A Triton among the Minnows?
  86. Intradialytic systolic blood pressure changes and risk of mortality
  87. Post-Transplant Anemia Has Strong Influences on Renal and Patient Outcomes in Living Kidney Transplant Patients
  88. Longitudinal trends in serum ferritin levels and associated factors in a national incident hemodialysis cohort
  89. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients
  90. Early Nephrology Referral 6 Months Before Dialysis Initiation Can Reduce Early Death But Does Not Improve Long-Term Cardiovascular Outcome on Dialysis
  91. What Is Known and Unknown About Twice-Weekly Hemodialysis
  92. Current and Potential Therapeutic Strategies for Hemodynamic Cardiorenal Syndrome
  93. Kidney auto-transplantation: a nationwide analysis of an underutilized transplant modality
  94. Latest consensus and update on protein-energy wasting in chronic kidney disease
  95. Prevalence and Prognostic Implications of Vitamin D Deficiency in Chronic Kidney Disease
  96. Dietary L-Lysine Prevents Arterial Calcification in Adenine-Induced Uremic Rats
  97. Vitamin D Deficiency Predicts Decline in Kidney Allograft Function: A Prospective Cohort Study
  98. The Change History of the INDEPENDENT Study in the ClinicalTrials.gov Database
  99. Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline
  100. Multidetector-row computed tomography is useful to evaluate the therapeutic effects of bisphosphonates in glucocorticoid-induced osteoporosis
  101. Non-Invasive Magnetic Resonance Imaging in Rats for Prediction of the Fate of Grafted Kidneys from Cardiac Death Donors
  102. Renal transplantations from parents to siblings with autosomal recessive Alport syndrome caused by a rearrangement in an intronic antisense Alu element in the COL4A3 gene led to different outcomes
  103. Prognostic significance of left ventricular hypertrophy observed at dialysis initiation depends on the pre-dialysis use of erythropoiesis-stimulating agents
  104. A single daily dose enhances the adherence to immunosuppressive treatment in kidney transplant recipients: a cross-sectional study
  105. Reply to “FGF23 adds value to risk prediction in patients with chronic kidney disease”
  106. Plasma B-type natriuretic peptide level predicts kidney prognosis in patients with predialysis chronic kidney disease
  107. Orally Active Vitamin D for Potential Chemoprevention of Posttransplant Malignancy
  108. Implausible similarities in patient characteristics between two randomized controlled studies: a coincidence is unlikely
  109. Oral active vitamin d therapy as a potential chemoprevention against post-transplant malignancy
  110. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis
  111. Self-reported Sleep Duration and Prediction of Proteinuria: A Retrospective Cohort Study
  112. Combined Use of Vitamin D Status and FGF23 for Risk Stratification of Renal Outcome
  113. Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy
  114. Effects of nicorandil on the reduction of BNP levels in patients with chronic kidney disease
  115. Effects of chronic kidney disease and post-angiographic acute kidney injury on long-term prognosis after coronary artery angiography
  116. Impact of Age and Overt Proteinuria on Outcomes of Stage 3 to 5 Chronic Kidney Disease in a Referred Cohort
  117. Quiz Page June 2009
  118. Cardiac troponin T predicts occult coronary artery stenosis in patients with chronic kidney disease at the start of renal replacement therapy